Hikma Pharmaceuticals PLC
HKMPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,534,438 | $5,048,882 | $4,133,384 | $6,958,875 |
| - Cash | $188,000 | $205,000 | $270,000 | $426,000 |
| + Debt | $1,306,000 | $1,191,000 | $1,283,000 | $846,000 |
| Enterprise Value | $6,652,438 | $6,034,882 | $5,146,384 | $7,378,875 |
| Revenue | $3,127,000 | $2,875,000 | $2,517,000 | $2,553,000 |
| % Growth | 8.8% | 14.2% | -1.4% | – |
| Gross Profit | $1,415,000 | $1,407,000 | $1,238,000 | $1,301,000 |
| % Margin | 45.3% | 48.9% | 49.2% | 51% |
| EBITDA | $727,000 | $559,000 | $688,000 | $766,000 |
| % Margin | 23.2% | 19.4% | 27.3% | 30% |
| Net Income | $359,000 | $190,000 | $188,000 | $421,000 |
| % Margin | 11.5% | 6.6% | 7.5% | 16.5% |
| EPS Diluted | 3.22 | 1.72 | 1.68 | 3.62 |
| % Growth | 87.2% | 2.4% | -53.6% | – |
| Operating Cash Flow | $564,000 | $608,000 | $530,000 | $638,000 |
| Capital Expenditures | -$235,000 | -$204,000 | -$225,000 | -$229,000 |
| Free Cash Flow | $329,000 | $404,000 | $305,000 | $409,000 |